Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 03/10

Trade details

Type: Insider sale
Amount: $107,623.44
Shares · price: 6,693 sh · $16.08 a share
Held after: 451,815 sh
Stock: KalVista Pharmaceuticals KALV
Person: Benjamin L. PalleikoCEO
Trade date: 26/03/09
Filed: 26/03/10
Days to filing: 1 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/07~04/08

Benjamin L. Palleiko's recent trades

Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$156.2K
10,034 sh
$156.2K
Filed 02/24
Traded 02/23

Benjamin L. Palleiko, CEO — sold $107.6K of KalVista Pharmaceuticals KALV · 1.5% of holdings | Whalegun